Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States

American Journal of Medicine

Volumn 115, Issue 4, 2003, Pages 291-297

  Agarwal, Rajiv ^a,g   Nissenson, Allen R ^b   Batlle, Daniel ^c   Coyne, Daniel W ^d   Trout, J Richard ^e   Warnock, David G ^f  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e RUTGERS UNIVERSITY   (United States)

^f University of Alabama at Birmingham   (United States)

^g INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRY WEIGHT; ETHNOLOGY; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTICENTER STUDY; POPULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNITED STATES;

EID: 0041878535     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(03)00366-8     Document Type: Article

References (43)

1. Hyman D.J., Pavlik V.N. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 345:2001;479-486.
2. Horl M.P., Horl W.H. Hemodialysis-associated hypertension pathophysiology and therapy . Am J Kidney Dis. 39:2002;227-244.
3. Salem M.M. Hypertension in the hemodialysis population a survey of 649 patients . Am J Kidney Dis. 26:1995;461-468.
4. Rocco M.V., Yan G., Heyka R.J., et al. Risk factors for hypertension in chronic hemodialysis patients baseline data from the HEMO study . Am J Nephrol. 21:2001;280-288.
5. United States Renal Data System. USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, Maryland: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2002.
6. Agarwal R., Lewis R.R. Prediction of hypertension in chronic hemodialysis patients. Kidney Int. 60:2001;1982-1989.
7. He J., Whelton P.K. Epidemiology and prevention of hypertension. Med Clin North Am. 81:1997;1077-1097.
8. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, Maryland: National Institutes of Health; 1997:1-68. NIH publication 98-4080.
9. Physical Status The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee . 1995;World Health Organization, Geneva, Switerland.
10. Rahman M., Griffin V., Kumar A., et al. A comparison of standardized versus "usual" blood pressure measurements in hemodialysis patients. Am J Kidney Dis. 39:2002;1226-1230.
11. Cheigh J.S., Milite C., Sullivan J.F., et al. Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis. 19:1992;453-459.
12. Erturk S., Ertug A.E., Ates K., et al. Relationship of ambulatory blood pressure monitoring data to echocardiographic findings in haemodialysis patients. Nephrol Dial Transplant. 11:1996;2050-2054.
13. Goldsmith D.J., Covic A.C., Venning M.C., Ackrill P. Ambulatory blood pressure monitoring in renal dialysis and transplant patients. Am J Kidney Dis. 29:1997;593-600.
14. Cannella G., Paoletti E., Ravera G., et al. Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients. Kidney Int. 58:2000;260-268.
15. Ritz E., Strumpf C., Katz F., et al. Hypertension and cardiovascular risk factors in hemodialyzed diabetic patients. Hypertension. 7:1985;II118-II124.
16. Foley R.N., Parfrey P.S., Harnett J.D., et al. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int. 49:1996;1379-1385.
17. Tomita J., Kimura G., Inoue T., et al. Role of systolic blood pressure in determining prognosis of hemodialyzed patients. Am J Kidney Dis. 25:1995;405-412.
18. Mazzuchi N., Carbonell E., Fernandez-Cean J. Importance of blood pressure control in hemodialysis patient survival. Kidney Int. 58:2000;2147-2154.
19. Charra B., Calemard E., Ruffet M., et al. Survival as an index of adequacy of dialysis. Kidney Int. 41:1992;1286-1291.
20. Coresh J., Wei G.L., McQuillan G., et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States findings from the third National Health and Nutrition Examination Survey (1988-1994) . Arch Intern Med. 161:2001;1207-1216.
21. Zager P., Nikolic J., Raj D.S., et al. Hypertension in end-stage renal disease patients. Curr Opin Nephrol Hypertens. 9:2000;279-283.
22. Brenner B.M., Cooper M.E., de Zeeuw D., et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 345:2001;861-869.
23. Lewis E.J., Hunsicker L.G., Clarke W.R., et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 345:2001;851-860.
24. Rahman M., Dixit A., Donley V., et al. Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients. Am J Kidney Dis. 33:1999;498-506.
25. Agarwal R. Supervised atenolol therapy in management of hemodialysis hypertension. Kidney Int. 55:1999;1528-1535.
26. Agarwal R., Lewis R.R., Davis J.L., Becker B. Lisinopril therapy for hemodialysis hypertension-hemodynamic and endocrine responses. Am J Kidney Dis. 38:2001;1245-1250.
27. Batlle D.C., von Riotte A., Lang G. Delayed hypotensive response to dialysis in hypertensive patients with end-stage renal disease. Am J Nephrol. 6:1986;14-20.
28. Rahman M., Fu P., Sehgal A.R., Smith M.C. Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients. Am J Kidney Dis. 35:2000;257-265.
29. Agodoa L.Y., Appel L., Bakris G.L., et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis a randomized controlled trial . JAMA. 285:2001;2719-2728.
30. Tozawa M., Iseki K., Fukiyama K. Hypertension in dialysis patients a cross-sectional analysis . Nippon Jinzo Gakkai Shi. 38:1996;129-135.
31. Saracho R., Martin-Malo A., Martinez I., et al. Evaluation of the Losartan in Hemodialysis (ELHE) study. Kidney Int Suppl. 68:1998;S125-S129.
32. Izzo J.L. Jr, Santarosa R.P., Larrabee P.S., et al. Increased plasma norepinephrine and sympathetic nervous activity in essential hypertensive and uremic humans effects of clonidine . J Cardiovasc Pharmacol. 10:(suppl 12):1987;S225-S229.
33. Agarwal R. Strategies and feasibility of hypertension control in a prevalent hemodialysis cohort. Clin Nephrol. 53:2000;344-353.
34. Mittal S.K., Kowalski E., Trenkle J., et al. Prevalence of hypertension in a hemodialysis population. Clin Nephrol. 51:1999;77-82.
35. Jaeger J.Q., Mehta R.L. Assessment of dry weight in hemodialysis an overview . J Am Soc Nephrol. 10:1999;392-403.
36. Scribner B.H. Can antihypertensive medications control blood pressure in haemodialysis patients yes or no? Nephrol Dial Transplant. 14:1999;2599-2601.
37. Leypoldt J.K., Cheung A.K., Delmez J.A., et al. Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int. 61:2002;266-275.
38. Michael B., Coyne D.W., Fishbane S., et al. Sodium ferric gluconate complex in hemodialysis patients adverse reactions compared to placebo and iron dextran . Kidney Int. 61:2002;1830-1839.
39. Thylen P., Ericsson F., Odar-Cederlof I., Kjellstrand C.M. Hypertension profiling by total body water (TBW) determinations in patients on chronic hemodialysis. Int J Artif Organs. 14:1991;18-22.
40. Ozkahya M., Ok E., Cirit M., et al. Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant. 13:1998;1489-1493.
41. Luik A.J., Sande F.M., Weideman P., et al. The influence of increasing dialysis treatment time and reducing dry weight on blood pressure control in hemodialysis patients a prospective study . Am J Nephrol. 21:2001;471-478.
42. Pierratos A., Ouwendyk M., Francoeur R., et al. Nocturnal hemodialysis three-year experience . J Am Soc Nephrol. 9:1998;859-868.
43. Pickering T.G., Gribbin B., Oliver D.O. Baroreflex sensitivity in patients on long-term haemodialysis. Clin Sci. 43:1972;645-657.